p53 gene therapy not only increases tumor cells’ sensitivity to chemotherapy but also significantly enhances anti-tumor activity while reducing the dose of chemotherapeutic agents, thereby reducing the toxicity of high-dose chemotherapy agents to humans. The gene discussed is TP53; the disease is neoplasm.